Irina Kolobova

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also affiliated with ViiV Healthcare (Spain)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Short‐term intestinal lipase inhibition in normal‐weight individuals does not affect postprandial peptide YY 3 ‐36 and glucagon‐like peptide‐1 levels, hunger or satiety”.

Short‐term intestinal lipase inhibition in normal‐weight individuals does not affect postprandial peptide YY 3 ‐36 and glucagon‐like peptide‐1 levels, hunger or satiety

Diabetes Obesity and Metabolism(2020)10.1111/dom.14182

N/A

0DataRank · unranked

4 citations

Irina Kolobova, Bruce M. Wolfe, Jonathan Q. Purnell, Nga Nguyen